Evidence map›Paper›PMID 22796189›Full record

ArticleCellular signalling2012

Analysis of substrate specificity and cyclin Y binding of PCTAIRE-1 kinase.

Saifeldin N Shehata, Roger W Hunter, Eriko Ohta, Mark W Peggie, Hua Jane Lou, Frank Sicheri, Elton Zeqiraj, Benjamin E Turk, Kei Sakamoto

Open access · hybridAbstract read
In one paragraph

Article in Cellular signalling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Atypical cyclins: the extended family portrait.Cellular and molecular life sciences : CMLS · 2020
    Review
  7. Article
  8. Article
  9. Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Saifeldin N ShehataMRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, UK.
Roger W Hunter
Eriko Ohta
Mark W Peggie
Hua Jane Lou
Frank Sicheri
Elton Zeqiraj
Benjamin E Turk
Kei Sakamoto
University of Dundee · GBMRC Protein Phosphorylation and Ubiquitylation Unit · GBYale University · USLunenfeld-Tanenbaum Research Institute · CAMount Sinai Hospital · CA

Funding

Proteome-wide analysis of kinase phosphorylation specificity in yeastR01GM079498 · NIGMS · YALE UNIVERSITY · PI TURK, BENJAMIN E · 2007 to 2011
$1.8M
British Heart FoundationMedical Research Council MC_U127088492NIGMS NIH HHS R01 GM079498Wellcome Trust 092381
6 · The paper itself

Abstract

PCTAIRE-1 (cyclin-dependent kinase [CDK] 16) is a highly conserved serine/threonine kinase that belongs to the CDK family of protein kinases. Little is known regarding PCTAIRE-1 regulation and function and no robust assay exists to assess PCTAIRE-1 activity mainly due to a lack of information regarding its preferred consensus motif and the lack of bona fide substrates. We used positional scanning peptide library technology and identified the substrate-specificity requirements of PCTAIRE-1 and subsequently elaborated a peptide substrate termed PCTAIRE-tide. Recombinant PCTAIRE-1 displayed vastly improved enzyme kinetics on PCTAIRE-tide compared to a widely used generic CDK substrate peptide. PCTAIRE-tide also greatly improved detection of endogenous PCTAIRE-1 activity. Similar to other CDKs, PCTAIRE-1 requires a proline residue immediately C-terminal to the phosphoacceptor site (+1) for optimal activity. PCTAIRE-1 has a unique preference for a basic residue at +4, but not at +3 position (a key characteristic for CDKs). We also demonstrate that PCTAIRE-1 binds to a novel cyclin family member, cyclin Y, which increased PCTAIRE-1 activity towards PCTAIRE-tide >100-fold. We hypothesised that cyclin Y binds and activates PCTAIRE-1 in a way similar to which cyclin A2 binds and activates CDK2. Point mutants of cyclin Y predicted to disrupt PCTAIRE-1-cyclin Y binding severely prevented complex formation and activation of PCTAIRE-1. We have identified PCTAIRE-tide as a powerful tool to study the regulation of PCTAIRE-1. Our understanding of the molecular interaction between PCTAIRE-1 and cyclin Y further facilitates future investigation of the functions of PCTAIRE-1 kinase.

Indexed as

Amino Acid SequenceBinding SitesCyclin-Dependent KinasesCyclinsHEK293 CellsHumansKineticsMutationPeptide LibraryProtein BindingProtein Structure, TertiaryRecombinant ProteinsSubstrate SpecificityTransfectionCCNY protein, humanCyclin-Dependent KinasesCyclinsPCTAIRE-1 protein kinasePeptide LibraryRecombinant Proteins

Identifiers

PMID22796189
PMCPMC3590450
OpenAlexW2058571348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.